Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 943 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Fidelity Investments Boston, Massachusetts	USD 13.9 M	-USD 27.2 k	-6,790	-0.2%
2	2 Column Group San Francisco, California	USD 11.4 M	–	–	–
3	3 EcoR1 Capital San Francisco, California	USD 10.9 M	–	–	–
4	4 Alkeon Capital Management New York	USD 6.74 M	–	–	–
5	5 OrbiMed New York	USD 6.68 M	–	–	–
6	6 Suvretta Capital Management New York	USD 6.09 M	+USD 2.56 M	+640,179	+51%
7	7 Millennium Management New York	USD 4.89 M	+USD 347 k	+86,631	+6%
8	8 Vanguard Group Malvern, Pennsylvania	USD 4.31 M	-USD 268 k	-66,869	-5%
9	9 Silverarc Capital Management Boston, Massachusetts	USD 3.87 M	+USD 507 k	+126,688	+12%
10	10 Boxer Capital San Diego, California	USD 3.37 M	–	–	–
11	11 BlackRock New York	USD 3.32 M	+USD 959 k	+239,601	+30%
12	12 Invus Financial Advisors New York	USD 3.22 M	–	–	–
13	13 Prosight Management Dallas, Texas	USD 3 M	+USD 3.75 M	+936,334	Nuevas
14	EC 14 Euclidean Capital New York	USD 2.39 M	–	–	–
15	15 Memorial Sloan Kettering Cancer Center New York	USD 1.93 M	–	–	–
16	16 ArrowMark Colorado Holdings Denver, Colorado	USD 1.74 M	-USD 2.96 M	-739,346	-58%
17	17 D.E. Shaw & Co New York	USD 1.71 M	+USD 112 k	+27,901	+6%
18	18 DAFNA Capital Management Los Angeles, California	USD 1.32 M	-USD 9.6 k	-2,400	-0.6%
19	19 Renaissance Technologies New York	USD 1.28 M	-USD 186 k	-46,469	-10%
20	AG 20 Artal Group Luxembourg	USD 1.28 M	–	–	–
21	21 UBS O'Connor Chicago, Illinois	USD 1.1 M	-USD 72.3 k	-18,053	-5%
22	22 Monaco Asset Management Monaco	USD 1.09 M	-USD 94.3 k	-23,559	-6%
23	23 Geode Capital Management Boston, Massachusetts	USD 909 k	-USD 160 k	-40,065	-12%
24	24 Oasis Management Company Grand Cayman, Cayman Islands	USD 872 k	–	–	–
25	25 GSA Capital Partners London, United Kingdom	USD 722 k	+USD 700 k	+174,965	+346%

Oric Pharmaceuticals ORIC Capitalización de mercado USD 943 M

Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 943 M